The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Emergent BioSolutions, Inc....
August 31 2016 - 12:50PM
Business Wire
Law Offices of Howard G. Smith announces that a class
action lawsuit has been filed on behalf of investors who purchased
Emergent BioSolutions, Inc. (“Emergent” or the “Company”) (NYSE:
EBS) securities between January 11, 2016 and June 21, 2016,
inclusive (the “Class Period”). Emergent investors have
until September 19, 2016 to file a lead plaintiff
motion.
Investors suffering losses on their Emergent investments are
encouraged to contact the Law Offices of Howard G. Smith to discuss
their legal rights in this class action at 888-638-4847 or by email
to howardsmith@howardsmithlaw.com. Investors with large losses are
encouraged to contact the firm to discuss their legal rights to
serve as a class representative.
Emergent is a specialty biopharmaceutical company that develops,
manufactures and sells specialized products to healthcare providers
and governments in the United States and internationally. One of
the Company’s most lucrative contracts with the United States
government is for the supply of a U.S. Strategic National Stockpile
of anthrax vaccine.
According to the Complaint, Emergent issued false and misleading
statements relating to the renewal of the U.S. government contract,
including whether the Company misled investors regarding the U.S.
government’s shift in focus from first-generation anthrax vaccines
produced by Emergent, to next generation vaccines produced by other
manufacturers. Following the news of the government’s change in
policy, the Company’s shares fell sharply in value.
If you purchased shares of Emergent during the Class Period you
may move the Court no later than September 19,
2016 to ask the Court to appoint you as lead plaintiff if
you meet certain legal requirements. To be a member of the Class
you need not take any action at this time; you may retain counsel
of your choice or take no action and remain an absent member of the
Class. If you wish to learn more about this action, or if
you have any questions concerning this announcement or your rights
or interests with respect to these matters, please contact Howard
G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol
Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215)
638-4847, toll-free at (888) 638-4847, or by email
to howardsmith@howardsmithlaw.com, or visit our website at
http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160831006184/en/
Law Offices of Howard G. SmithHoward G. Smith,
Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2024 to May 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From May 2023 to May 2024